D.C. A.G. Schwalb Secures Over $2.3 Million From Suboxone Maker Accused of Monopolizing Opioid Treatment Drug
June 03, 2023
June 03, 2023
WASHINGTON, June 3 -- District of Columbia Attorney General Brian L. Schwalb issued the following news release on June 2, 2023:
Attorney General Brian L. Schwalb today announced that Indivior, Inc - which makes the opioid addiction treatment medication Suboxone - will pay the District approximately $2.3 million as part of a 42-state settlement that resolves allegations that the company orchestrated an anticompetitive scheme to block generic competition for Suboxone. The alleged sche . . .
Attorney General Brian L. Schwalb today announced that Indivior, Inc - which makes the opioid addiction treatment medication Suboxone - will pay the District approximately $2.3 million as part of a 42-state settlement that resolves allegations that the company orchestrated an anticompetitive scheme to block generic competition for Suboxone. The alleged sche . . .